Secor Capital Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Secor Capital Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,848	Closed	-$585K	–	717
2017 Q4	$585K	Buy	+10,848	New	+$594K	0.02%	344
2017 Q3	–	Sell	-31,286	Closed	-$1.88M	–	603
2017 Q2	$1.88M	Buy	+31,286	New	+$1.78M	0.17%	189

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Secor Capital Advisors's BIVV Position: Q1 2018 in Review

Secor Capital Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,848 shares — an estimated $585K sold.

Secor Capital Advisors first reported a position in BIVV in Q2 2017 and held it in 2 quarters. The position peaked at $1.88M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Secor Capital Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Secor Capital Advisors sold 10,848 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $585K.
Secor Capital Advisors first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 2 quarters.
Secor Capital Advisors's Bioverativ Inc. Common Stock position peaked at $1.88M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Secor Capital Advisors's 13F filing for Q1 2018, filed 15 May 2018.